Daniel Umbricht Selected Research

Daniel Umbricht Research Topics

Disease

16	Schizophrenia (Dementia Praecox) 06/2021 - 01/2003
5	Autism Spectrum Disorder 12/2020 - 08/2017
5	Psychotic Disorders (Schizoaffective Disorder) 05/2016 - 03/2009
3	Autistic Disorder (Autism) 12/2020 - 08/2017
2	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2021
2	Mental Disorders (Mental Disorder) 01/2021 - 08/2018
2	Treatment-Resistant Schizophrenia 03/2017 - 05/2016
2	Cognitive Dysfunction 01/2013 - 05/2003
2	Alzheimer Disease (Alzheimer's Disease) 05/2003 - 09/2002
1	Hypokinesia (Bradykinesia) 01/2021
1	Disease Progression 01/2021
1	Movement Disorders (Movement Disorder) 01/2021
1	Tremor (Tremors) 01/2021
1	Major Depressive Disorder (Major Depressive Disorders) 01/2020
1	beta-Thalassemia (Cooley's Anemia) 08/2018
1	Syndrome (Syndromes) 05/2016
1	Tachycardia (Tachyarrhythmias) 05/2016
1	Tobacco Use Disorder (Nicotine Dependence) 01/2013
1	Hallucinations (Hallucination) 11/2011
1	Prodromal Symptoms 08/2009
1	Weight Gain 01/2007
1	Amyloid Plaque 05/2003
1	Dementia (Dementias) 05/2003
1	Nervous System Diseases (Neurological Disorders) 09/2002
1	Genetic Predisposition to Disease (Genetic Predisposition) 09/2002

Drug/Important Bio-Agent (IBA)

7	Antipsychotic Agents (Antipsychotics)IBA 06/2021 - 02/2003
5	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 06/2014 - 01/2003
4	Biomarkers (Surrogate Marker)IBA 12/2020 - 08/2017
3	(4- (3- fluoro- 5- trifluoromethylpyridin- 2- yl)piperazin- 1- yl)(5- methanesulfonyl- 2- (2,2,2- trifluoro- 1- methylethoxy)phenyl)methanoneIBA 08/2018 - 06/2014
3	N-Methylaspartate (NMDA)IBA 02/2013 - 01/2003
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2002
2	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 08/2009
2	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2019 - 08/2017
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 08/2018 - 06/2014
2	Vasopressins (Vasopressin)IBA 08/2017 - 08/2017
2	(6- chloro- 1- (2- (dimethylamino)ethyl)indol- 3- yl)- spiro(1H- isobenzofuran- 3,4'- piperidine)- 1'- yl- methanoneIBA 08/2017 - 08/2017
2	Risperidone (Risperdal Consta)FDA LinkGeneric 05/2016 - 06/2014
1	SynucleinsIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 06/2021
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 06/2021
1	Monoamine Oxidase (MAO)IBA 01/2021
1	alpha-SynucleinIBA 01/2021
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2020
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2020
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 01/2020
1	Antidepressive Agents (Antidepressants)IBA 01/2020
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2020
1	Serotonin (5 Hydroxytryptamine)IBA 01/2020
1	mesoglycanIBA 01/2019
1	Glycine Plasma Membrane Transport ProteinsIBA 01/2018
1	Clozapine (Clozaril)FDA LinkGeneric 05/2016
1	Paliperidone Palmitate FDA Link 06/2014
1	Aripiprazole (Abilify)FDA Link 06/2014
1	N- ((3S)- 1- azabicyclo(2.2.2)oct- 3- yl)- 1H- indazole- 3- carboxamide hydrochlorideIBA 06/2014
1	Metabotropic Glutamate 5 ReceptorIBA 01/2013
1	Nicotine FDA Link 01/2013
1	Glutamate Receptors (Glutamate Receptor)IBA 09/2012
1	Phencyclidine (Angel Dust)IBA 09/2012
1	Cholinergic Antagonists (Anticholinergics)IBA 11/2011
1	Amyloid beta-PeptidesIBA 05/2003
1	AntibodiesIBA 05/2003
1	Serotonin 5-HT2 Receptor AgonistsIBA 01/2003
1	Psilocybin (Psilocibin)IBA 01/2003
1	Ketamine FDA LinkGeneric 01/2003
1	Tissue Inhibitor of MetalloproteinasesIBA 09/2002
1	Tissue Inhibitor of Metalloproteinase-1IBA 09/2002

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2013
3	Ambulatory Care (Outpatient Care) 11/2014 - 03/2009
1	Time-to-Treatment 05/2016
1	Self Administration (Administration, Self) 01/2013
1	Polypharmacy 11/2011
1	Activities of Daily Living (ADL) 05/2003